This protocol is judged by an institutional evaluate board, an unbiased group that testimonials any clinical trials involving individuals. If a study involves a Schedule I drug, once the board approves the protocol as ethical, the scientists should apply for an investigational new drug (IND) range through the FDA.And Considering that the copyright